Karyopharm Therapeutics Inc. (KPTI) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading KPTI…

Karyopharm Therapeutics Inc. (KPTI) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Karyopharm Therapeutics Inc.

KPTI · CIK 1503802

4 · Oct 2, 2026 · Chief Accounting Officer Abate Kristin sold 378 shares at $1.19/share ($450)

4

Chief Accounting Officer Abate Kristin sold 378 shares at $1.19/share ($450)

Filed: Oct 2, 2026
Period: Oct 1, 2026
Accession: 0001193125-26-412209
Filer: Karyopharm Therapeutics Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov